Fatty Liver
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kotronen A Westerbacka J Bergholm R Pietilainen KH Yki-Jarvinen H. Liver Fat in the Metabolic Syndrome. J Clin Endocrinol Metab. In press.
Wasastjerna C, Reissell P, Karjalainen J, Ekelund P. Fatty liver in diabetes. A cytological study. Acta Med Scand. 1972; 191: 225–228.
Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord. 1995; 19: 841–845.
Nikkila EA, Taskinen MR. Relation between H.D.L.-cholesterol levels and triglyceride metabolism. Lancet. 1978; 2: 892.
Bergholm R, Westerbacka J, Vehkavaara S, Seppala-Lindroos A, Goto T, Yki-Jarvinen H. Insulin sensitivity regulates autonomic control of heart rate variation independent of body weight in normal subjects. J Clin Endocrinol Metab. 2001; 86: 1403–1409.
Liou I, Kowdley KV. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol. 2006; 40 (3 Suppl 1): S11–S116.
Ohlson LO, Larsson B, Bjorntorp P, Eriksson H, Svardsudd K, Welin L, Tibblin G, Wilhelmsen L. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia. 1988; 31: 798–805.
Targher G Bertolini L Padovani R Rodella S Tessari R Zenari L Day C Arcaro G Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;
Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 2003; 38: 420–427.
Nakamuta M, Kohjima M, Morizono S, Kotoh K, Yoshimoto T, Miyagi I, Enjoji M. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med. 2005; 16: 631–635.
Makkonen J Westerbacka J Kolak M Sutinen J Corner A Hamsten A Fisher RM Yki-Jarvinen H. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue but not in cultured monocyte-derived macrophages is associated with liver fat in human obesity. Int J Obes (Lond). 2007.
Kolak M Westerbacka J Velagapudi VR Wågsäter D Yetukuri L Makkonen J Rissanen A Hakkinen AM Lindell M Hamsten A Eriksson P Fisher RM Oresic M Yki-Jarvinen H. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes. In press.
Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 2000; 26: 98–106.
Valtuena S Pellegrini N Ardigo D Del Rio D Numeroso F Scazzina F Monti L Zavaroni I Brighenti F. Dietary glycemic index and liver steatosis. Am J Clin Nutr. 84:136–142 2006; quiz 268–269.
Yki-Jarvinen H. Prediction and prevention of non-insulin-dependent diabetes mellitus. In: Williams G Pickup J eds. Textbook of Diabetes. 2001; 2 ed. Oxford: Blackwell 83.1–83.13.
Targher G. Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease. J Hepatol. 45:879–881 2006; author reply 881–882.
Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology. 2006; 44: 27–33.